Agilent opens new laboratory facility in Bangalore.

Jointly, the lab and center cover 8,000 square feet, making this the biggest Agilent research service in the world. ‘India is still one of the most important markets for Agilent globally, with a significant presence of high-end R&D in pharmaceuticals and biotechnology,’ said Parmeet Ahuja, Nation General Manager, Agilent Technologies, India. ‘This is the first Agilent lab facility where development of application solutions, customer interactions and training may happen in parallel. ‘ Originally opened in 2006, the Bangalore center serves Agilent’s clients across India. Customers now have access to Agilent’s newest high-end items, including the 7700 Series ICP-MS, 7000B GC-QQQ, 6490 QQQ, 6540 QTOF and the Agilent 1290 and 1260 Infinity LC.All security data were summarized regarding to study group. Statistical Analysis The per-protocol population was the primary population for the analysis of the primary and secondary end points & most exploratory end points. The analysis of most episodes of community-acquired pneumonia was based on the modified intention-to-treat population. A complete of 130 primary end-point events were required to have enough statistical power for the final analysis; this quantity was determined by using the conditional binomial strategy described by Breslow and Time, 28 acquiring the specificity and sensitivity of the serotype-specific urinary antigen detection assay into account.